Click Here for 5% Off Your First Aladdin Purchase!

Otamixaban - ≥98%, high purity , Coagulation factor X inhibitor, CAS No.193153-04-7, Coagulation factor X inhibitor

  • Moligand™
  • ≥98%
Item Number
O125049
Grouped product items
SKUSizeAvailabilityPrice Qty
O125049-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$414.90
O125049-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,781.90

Basic Description

SynonymsOtamixaban|193153-04-7|FXV673|FXV-673|XRP0673|XRP-0673|CHEMBL46618|RPR130673|RPR-130673|Methyl (2R,3R)-2-(3-carbamimidoylbenzyl)-3-((4-(1-oxidopyridin-4-yl)benzoyl)amino)butanoate|Otamixaban [INN]|1ksn|methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsOtamixaban(FXV 673) is an intravenous direct factor Xa inhibitor.Otamixaban is useful for thromboembolic disorders.
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionCoagulation factor X inhibitor
Product Description

Otamixaban(FXV673) is a potent (Ki = 0.5 nM), selective, rapid acting, competitive and reversible fXa inhibitor that effectively inhibits both free and prothrombinase-bound fXa.

Product Properties

ALogP2

Associated Targets

F10 Tclin Coagulation factor X 16 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TMPRSS2 Tchem Transmembrane protease serine 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PRSS1 Tclin Trypsin-1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

F2 Tclin Prothrombin 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[4-(1-oxidopyridin-1-ium-4-yl)benzoyl]amino]butanoate
INCHI InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1
InChi Key PFGVNLZDWRZPJW-OPAMFIHVSA-N
Canonical SMILES CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-]
Isomeric SMILES C[C@H]([C@@H](CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-]
PubChem CID 5496659
Molecular Weight 448.53

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO

Related Documents

References

1. Guertin KR, Gardner CJ, Klein SI, Zulli AL, Czekaj M, Gong Y, Spada AP, Cheney DL, Maignan S, Guilloteau JP et al..  (2002)  Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity..  Bioorg Med Chem Lett,  12  (12): (1671-4).  [PMID:12039587]
2. Rensi S, Altman RB, Liu T, Lo YC, McInnes G, Derry A, Keys A.  (2020)  Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells..  ChemRxiv,  129  (3): (589-97).  [PMID:32511288]
3. Hu X, Shrimp JH, Guo H, Xu M, Chen CZ, Zhu W, Zakharov AV, Jain S, Shinn P, Simeonov A et al..  (2021)  Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19..  ACS Pharmacol Transl Sci,  (3): (1124-1135).  [PMID:34136758]

Solution Calculators